Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 154

1.

CDKN2A germline mutations in individuals with cutaneous malignant melanoma.

Orlow I, Begg CB, Cotignola J, Roy P, Hummer AJ, Clas BA, Mujumdar U, Canchola R, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Wilcox H, Busam K, From L, Berwick M; GEM Study Group.

J Invest Dermatol. 2007 May;127(5):1234-43. Epub 2007 Jan 11.

PMID:
17218939
[PubMed - indexed for MEDLINE]
Free Article
2.

CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.

Pastorino L, Bonelli L, Ghiorzo P, Queirolo P, Battistuzzi L, Balleari E, Nasti S, Gargiulo S, Gliori S, Savoia P, Abate Osella S, Bernengo MG, Bianchi Scarrà G.

Pigment Cell Melanoma Res. 2008 Dec;21(6):700-9. doi: 10.1111/j.1755-148X.2008.00512.x. Epub 2008 Oct 22.

PMID:
18983535
[PubMed - indexed for MEDLINE]
3.

Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma.

Platz A, Hansson J, Månsson-Brahme E, Lagerlof B, Linder S, Lundqvist E, Sevigny P, Inganäs M, Ringborg U.

J Natl Cancer Inst. 1997 May 21;89(10):697-702.

PMID:
9168184
[PubMed - indexed for MEDLINE]
Free Article
4.

Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.

Tsao H, Zhang X, Kwitkiwski K, Finkelstein DM, Sober AJ, Haluska FG.

Arch Dermatol. 2000 Sep;136(9):1118-22.

PMID:
10987867
[PubMed - indexed for MEDLINE]
5.

CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.

Della Torre G, Pasini B, Frigerio S, Donghi R, Rovini D, Delia D, Peters G, Huot TJ, Bianchi-Scarra G, Lantieri F, Rodolfo M, Parmiani G, Pierotti MA.

Br J Cancer. 2001 Sep 14;85(6):836-44.

PMID:
11556834
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study.

Berwick M, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Busam K, From L, Mujumdar U, Wilcox H, Begg CB; GEM Study Group.

Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1520-5.

PMID:
16896043
[PubMed - indexed for MEDLINE]
Free Article
7.

CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.

Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hansson J.

Cancer Res. 2000 Dec 15;60(24):6864-7.

PMID:
11156381
[PubMed - indexed for MEDLINE]
Free Article
8.

Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.

Lal G, Liu L, Hogg D, Lassam NJ, Redston MS, Gallinger S.

Genes Chromosomes Cancer. 2000 Apr;27(4):358-61.

PMID:
10719365
[PubMed - indexed for MEDLINE]
9.

Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma.

Buecher B, Gauthier-Villars M, Desjardins L, Lumbroso-Le Rouic L, Levy C, De Pauw A, Bombled J, Tirapo C, Houdayer C, Bressac-de Paillerets B, Stoppa-Lyonnet D.

Fam Cancer. 2010 Dec;9(4):663-7. doi: 10.1007/s10689-010-9379-9.

PMID:
20842456
[PubMed - indexed for MEDLINE]
10.

Germline CDKN2A mutations are rare in child and adolescent cutaneous melanoma.

Berg P, Wennberg AM, Tuominen R, Sander B, Rozell BL, Platz A, Hansson J.

Melanoma Res. 2004 Aug;14(4):251-5.

PMID:
15305154
[PubMed - indexed for MEDLINE]
11.

Prevalence of 9p21 deletions in UK melanoma families.

Mistry SH, Taylor C, Randerson-Moor JA, Harland M, Turner F, Barrett JH, Whitaker L, Jenkins RB, Knowles MA, Bishop JA, Bishop DT.

Genes Chromosomes Cancer. 2005 Nov;44(3):292-300.

PMID:
16032697
[PubMed - indexed for MEDLINE]
12.

Germline CDKN2A/p16 mutations are rare in multiple primary and familial malignant melanoma in German patients.

Lukowsky A, Schäfer-Hesterberg G, Sterry W, Voit C.

J Dermatol Sci. 2008 Feb;49(2):163-5. Epub 2007 Sep 24. No abstract available.

PMID:
17890059
[PubMed - indexed for MEDLINE]
13.

CDKN2A variants in a population-based sample of Queensland families with melanoma.

Aitken J, Welch J, Duffy D, Milligan A, Green A, Martin N, Hayward N.

J Natl Cancer Inst. 1999 Mar 3;91(5):446-52.

PMID:
10070944
[PubMed - indexed for MEDLINE]
Free Article
14.

High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma families.

Mantelli M, Barile M, Ciotti P, Ghiorzo P, Lantieri F, Pastorino L, Catricalà C, Torre GD, Folco U, Grammatico P, Padovani L, Pasini B, Rovini D, Queirolo P, Rainero ML, Santi PL, Sertoli RM, Goldstein AM, Bianchi-Scarrà G; Società Italiana Dermatologia; Gruppo Italiano Studi Epidemiologici in Dermatologia.

Am J Med Genet. 2002 Jan 22;107(3):214-21.

PMID:
11807902
[PubMed - indexed for MEDLINE]
15.

Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients.

Kannengiesser C, Brookes S, del Arroyo AG, Pham D, Bombled J, Barrois M, Mauffret O, Avril MF, Chompret A, Lenoir GM, Sarasin A; French Hereditary Melanoma Study Group, Peters G, Bressac-de Paillerets B.

Hum Mutat. 2009 Apr;30(4):564-74. doi: 10.1002/humu.20845.

PMID:
19260062
[PubMed - indexed for MEDLINE]
16.

Population-based prevalence of CDKN2A mutations in Utah melanoma families.

Eliason MJ, Larson AA, Florell SR, Zone JJ, Cannon-Albright LA, Samlowski WE, Leachman SA.

J Invest Dermatol. 2006 Mar;126(3):660-6.

PMID:
16397522
[PubMed - indexed for MEDLINE]
Free Article
17.

BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.

Monnerat C, Chompret A, Kannengiesser C, Avril MF, Janin N, Spatz A, Guinebretière JM, Marian C, Barrois M, Boitier F, Lenoir GM, Bressac-de Paillerets B.

Fam Cancer. 2007;6(4):453-61. Epub 2007 Jul 12.

PMID:
17624602
[PubMed - indexed for MEDLINE]
18.

Germline CDKN2A mutations among Greek patients with early-onset and multiple primary cutaneous melanoma.

Stratigos AJ, Yang G, Dimisianos R, Nicolaou V, Stefanaki I, Katsambas AD, Tsao H.

J Invest Dermatol. 2006 Feb;126(2):399-401.

PMID:
16374456
[PubMed - indexed for MEDLINE]
Free Article
19.

Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas.

Helsing P, Nymoen DA, Ariansen S, Steine SJ, Maehle L, Aamdal S, Langmark F, Loeb M, Akslen LA, Molven A, Andresen PA.

Genes Chromosomes Cancer. 2008 Feb;47(2):175-84.

PMID:
18023021
[PubMed - indexed for MEDLINE]
20.

Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families.

Yakobson E, Shemesh P, Azizi E, Winkler E, Lassam N, Hogg D, Brookes S, Peters G, Lotem M, Zlotogorski A, Landau M, Safro M, Shafir R, Friedman E, Peretz H.

Eur J Hum Genet. 2000 Aug;8(8):590-6.

PMID:
10951521
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk